Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

World Cancer Day 2025, an approach to personalized care.
Opera or medicine? When Catherine Bollard stood at that crossroads of her career, that was the question in front of her. Despite her love of opera and a family populated with artists and performers, life experiences drew her down the path of medicine.
Meric Mericliler, MD, has joined the George Washington (GW) University Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in benign hematology.